Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp > .52 cents coming,,possibly lower me thinks.

<< Previous

Bullboard Posts

Next >>

Comment by ronrydellon Aug 24, 2021 11:18am

250 Views

Post# 33754687

RE:RE:RE:RE:.52 cents coming,,possibly lower me thinks.

I don't know DM can live with himself not personally sharing all this continuous pain we have month after month and year after year. From the time of his holding out the "MANILA ENVELOP IN 2007, until now...DM has enriched himself with not one, but later with two highly inflated salaries.

This RVX saga would be a great candidate for the CNBC saga "American Greed"..I think his basis is sixteen cents in the stock.....still in the money for him.

<< Previous

Bullboard Posts

Next >>

Silvercorp to expand into Ecuador with C$200M Adventus acquisition